Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?
To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in...
Saved in:
Published in | Clinical biochemistry Vol. 42; no. 9; pp. 791 - 795 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-9120 1873-2933 1873-2933 |
DOI | 10.1016/j.clinbiochem.2009.02.005 |
Cover
Abstract | To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).
The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (
n
=
25) and compared to healthy controls (
n
=
53).
sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33
±
0.27 vs 0.71
±
0.37 ng/mL,
p
<
0.001 and 0.51
±
0.45 vs 1.16
±
1.31 mg/L,
p
=
0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (
r
=
−
0.5,
p
<
0.001 and
r
=
−
0.34,
p
=
0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (
p
=
0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.
These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS. |
---|---|
AbstractList | Objective - To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). Design and methods - The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n = 25) and compared to healthy controls (n = 53). Results - sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 +/- 0.27 vs 0.71 +/- 0.37 ng/mL, p < 0.001 and 0.51 +/- 0.45 vs 1.16 +/- 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r = - 0.5, p < 0.001 and r = - 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. Conclusion - These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS. To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).OBJECTIVETo investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53).DESIGN AND METHODSThe soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53).sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.RESULTSsCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.CONCLUSIONThese novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS. To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS. To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS ( n = 25) and compared to healthy controls ( n = 53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 ± 0.27 vs 0.71 ± 0.37 ng/mL, p < 0.001 and 0.51 ± 0.45 vs 1.16 ± 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin ( r = − 0.5, p < 0.001 and r = − 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance ( p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS. |
Author | Tasci, Ilker Ozgurtas, Taner Erbil, Mehmet Kemal Ercin, Cemal Nuri Tapan, Serkan Dogru, Teoman |
Author_xml | – sequence: 1 givenname: Serkan surname: Tapan fullname: Tapan, Serkan email: serkantapan7@yahoo.com organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey – sequence: 2 givenname: Teoman surname: Dogru fullname: Dogru, Teoman organization: Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey – sequence: 3 givenname: Ilker surname: Tasci fullname: Tasci, Ilker organization: Department of Internal Medicine, Gulhane School of Medicine, Etlik, Ankara, Turkey – sequence: 4 givenname: Cemal Nuri surname: Ercin fullname: Ercin, Cemal Nuri organization: Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey – sequence: 5 givenname: Taner surname: Ozgurtas fullname: Ozgurtas, Taner organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey – sequence: 6 givenname: Mehmet Kemal surname: Erbil fullname: Erbil, Mehmet Kemal organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19232335$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUV1vFCEUJabGbqt_weCLfZrxArMzjC9Ns2o1aaKJ-kwYuNuyslCB3aT_Xia7GuOLTfi-5xzgnDNyEmJAQl4xaBmw_s2mNd6FyUVzh9uWA4wt8BZg-YQsmBxEw0chTsgCaqUZGYdTcpbzpm55J_tn5JSNXHAhlguy_xr9bvJIV-86oN7d6mDp3PPx_EuT0aMpLlCPe_SZ1tW18xOmcpFpfgg2xS2-pVeVHX7QEul9imVmxED1rXYhF6rLHaaYjZ9Hly-fk6dr7TO-OM7n5PuH999WH5ubz9efVlc3jemgL41BybVZMui1nPh6KRkzxujarAAD0HFpLB9tp2UnrbSw5r0dBtkxKYcehTgnrw-69U0_d5iL2rps0HsdMO6y6gc-CAbwX2A1WXZCsAp8eQTupi1adZ_cVqcH9dvSCrg8AEz9ak64VsYVPbtRknZeMVBziGqj_gpx1h8VcFVDrArjPwp_LnkEd3Xg1qRw7zCpbBwGg9almomy0T1C5RdcY77c |
CitedBy_id | crossref_primary_10_1371_journal_pone_0075178 crossref_primary_10_1016_j_plipres_2012_11_001 crossref_primary_10_1080_09537104_2017_1280146 crossref_primary_10_1016_j_clinbiochem_2010_12_003 crossref_primary_10_1016_j_metabol_2013_11_011 crossref_primary_10_1038_s41598_017_00933_y crossref_primary_10_5551_jat_6346 crossref_primary_10_1042_CS20140566 crossref_primary_10_1016_j_atherosclerosis_2015_02_051 crossref_primary_10_1016_j_cca_2018_10_028 crossref_primary_10_1152_ajprenal_00039_2014 crossref_primary_10_1186_s40064_016_3085_5 crossref_primary_10_1007_s11906_017_0756_8 crossref_primary_10_1016_j_freeradbiomed_2012_03_002 crossref_primary_10_1515_tjb_2016_0150 crossref_primary_10_1038_srep41681 crossref_primary_10_1097_MCA_0b013e3283315984 crossref_primary_10_1007_s00125_012_2818_4 crossref_primary_10_1016_j_atherosclerosis_2015_11_008 crossref_primary_10_1016_j_ijcme_2014_08_006 crossref_primary_10_1016_j_atherosclerosis_2014_12_042 crossref_primary_10_1186_s13098_023_01088_9 crossref_primary_10_1155_2018_6539385 crossref_primary_10_1373_clinchem_2010_151043 crossref_primary_10_1177_0004563214541969 crossref_primary_10_3109_07853890_2014_895588 crossref_primary_10_1007_s00380_011_0228_z |
Cites_doi | 10.1002/jcb.240450206 10.1016/S0021-9150(96)05980-1 10.1016/0304-4165(93)90013-X 10.1161/01.STR.32.2.580-b 10.1016/S0021-9150(99)00033-7 10.1055/s-0038-1646169 10.1016/S0021-9150(97)00232-3 10.1161/01.ATV.0000118279.74056.8a 10.1016/j.mehy.2006.12.069 10.1016/S0735-1097(02)02718-3 10.1159/000133513 10.1161/01.CIR.100.6.614 10.1093/clinchem/41.10.1504 10.1016/S0021-9150(01)00601-3 10.1093/clinchem/46.11.1723 10.1161/hc4501.099312 10.1016/j.atherosclerosis.2007.11.022 10.1258/000456306778520034 10.1093/clinchem/18.6.499 10.1016/j.jacc.2007.02.052 10.1177/15353702-0322805-29 10.1073/pnas.92.10.4342 10.1161/hc4401.099447 10.1096/fasebj.9.10.7542213 10.1097/00004872-199512010-00030 10.1161/01.HYP.0000100443.09293.4F 10.1016/j.metabol.2005.08.019 10.1152/ajpheart.2000.278.5.H1613 10.1161/01.CIR.0000074043.46437.44 10.1161/01.RES.85.8.663 10.1161/ATVBAHA.107.153262 10.1007/PL00000776 10.1161/01.CIR.97.10.953 10.1001/jama.297.8.842 10.1042/CS20060047 10.1161/01.CIR.96.2.396 10.1016/j.atherosclerosis.2005.05.011 10.1016/S0002-9149(97)00945-4 10.1093/clinchem/40.1.18 10.1073/pnas.97.13.6930 10.1161/01.CIR.103.4.491 10.1097/00001721-199710000-00002 10.1055/s-0038-1649788 10.1161/01.ATV.16.2.250 10.1161/01.HYP.0000130484.20501.df 10.2174/187152906776092659 10.1016/j.atherosclerosis.2008.01.001 |
ContentType | Journal Article |
Copyright | 2009 |
Copyright_xml | – notice: 2009 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.1016/j.clinbiochem.2009.02.005 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1873-2933 |
EndPage | 795 |
ExternalDocumentID | 19232335 10_1016_j_clinbiochem_2009_02_005 S0009912009000885 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29B 4.4 457 4G. 4R4 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO AAYJJ ABBQC ABFNM ABFRF ABGSF ABJNI ABLVK ABMAC ABMZM ABOCM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q G8K GBLVA HLW HVGLF HX~ HZ~ IHE J1W KOM LCYCR LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K UNMZH WUQ X7M XPP YYP YYQ ZGI ZUP ~G- AATTM AAXKI AAYWO AAYXX ABDPE ABWVN ACIEU ACLOT ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c406t-ce82ac5106a8b2f5811cccaccad30c00428cd29d4a848d8d0f26d778418876e33 |
IEDL.DBID | .~1 |
ISSN | 0009-9120 1873-2933 |
IngestDate | Thu Sep 04 23:12:12 EDT 2025 Sun Sep 28 01:09:02 EDT 2025 Mon Jul 21 06:03:50 EDT 2025 Thu Apr 24 23:05:24 EDT 2025 Wed Oct 01 05:19:55 EDT 2025 Fri Feb 23 02:25:26 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | sCD40L Bilirubin Gilbert's syndrome sP-selectin hs-CRP Atherosclerosis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c406t-ce82ac5106a8b2f5811cccaccad30c00428cd29d4a848d8d0f26d778418876e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19232335 |
PQID | 20084331 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_67273100 proquest_miscellaneous_20084331 pubmed_primary_19232335 crossref_citationtrail_10_1016_j_clinbiochem_2009_02_005 crossref_primary_10_1016_j_clinbiochem_2009_02_005 elsevier_sciencedirect_doi_10_1016_j_clinbiochem_2009_02_005 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-06-01 |
PublicationDateYYYYMMDD | 2009-06-01 |
PublicationDate_xml | – month: 06 year: 2009 text: 2009-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical biochemistry |
PublicationTitleAlternate | Clin Biochem |
PublicationYear | 2009 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Schwertner, Vítek (bib7) 2008; 198 Nakagami, Toyomura, Kinoshita, Morisawa (bib49) 1993; 1158 Denger, Jahn, Wende (bib32) 1999; 144 Hopkins, Wu, Hunt, James, Vincent, Williams (bib3) 1996; 16 Davì, Romano, Mezzetti (bib15) 1998; 97 Friedewald, Levy, Fredrickson (bib20) 1972; 18 Garlichs, John, Schmeisser (bib9) 2001; 104 Wagner (bib13) 1993; 70 Phipps (bib8) 2000; 97 Jialal, Devaraj, Venugopal (bib46) 2004; 44 Blann, Lip (bib39) 1997; 128 Blann, Dobrotova, Kubisz, McCollum (bib16) 1995; 74 Aukrust, Müller, Ueland, Berget, Aaser, Brunsvig (bib10) 1999; 100 Gokulakrishnan, Deepa, Mohan, Gross (bib35) 2006; 55 Ridker, Buring, Rifai (bib18) 2001; 103 Lip, Blann, Zarifis, Beevers, Lip, Beevers (bib14) 1995; 13 Varo, Nuzzo, Natal, Libby, Schönbeck (bib21) 2006; 111 van Es, Bout, Liu (bib1) 1993; 63 Varo, Vicent, Libby (bib11) 2003; 107 McCarty (bib44) 2007; 69 Ishizaka, Ishizaka, Takahashi, Yamakado, Hashimoto (bib26) 2001; 32 Breimer, Wannamethee, Ebrahim, Shaper (bib22) 1995; 41 Karmann, Hughes, Schechner, Fanslow, Pober (bib31) 1995; 92 McEver (bib36) 1990; 16 Schwertner, Jackson, Tolan (bib2) 1994; 40 Lindenblatt, Bordel, Schareck, Menger, Vollmar (bib41) 2004; 24 Vítek, Jirsa, Brodanová (bib23) 2002; 160 Ridker (bib45) 2007; 49 Novotny, Vítek (bib4) 2003; 228 Hirschfield, Alexander (bib19) 2006; 43 Tedder, Steeber, Chen, Engel (bib37) 1995; 9 Perlstein, Pande, Beckman, Creager (bib25) 2008; 28 Blann, Faragher, McCollum (bib40) 1997; 8 Mylonas, Kouretas (bib6) 1999; 13 Semb, van Wissen, Ueland (bib34) 2003; 41 Vachharajani, Work, Issekutz, Granger (bib42) 2000; 278 Schönbeck, Varo, Libby, Buring, Ridker (bib12) 2001; 104 Shimomura, Ogawa, Arai (bib17) 1998; 81 Mayer (bib48) 2000; 46 Yung, Leung, Yao, Chen, Huang (bib28) 2006; 6 Bjelakovic, Nikolova, Gluud, Simonetti, Gluud (bib29) 2007; 297 Mach, Schönbeck, Bonnefoy, Pober, Libby (bib33) 1997; 96 Schönbeck, Libby (bib30) 2001; 58 Taniyama, Griendling (bib27) 2003; 42 Bulmer, Blanchfield, Toth, Fassett, Coombes (bib5) 2008; 199 McEver (bib38) 1991; 45 Schwertner (bib24) 1998; 136 Hayashi, Takamiya, Yamaguchi (bib43) 1999; 85 Erdogan, Gullu, Yildirim (bib47) 2006; 184 van Es (10.1016/j.clinbiochem.2009.02.005_bib1) 1993; 63 Mach (10.1016/j.clinbiochem.2009.02.005_bib33) 1997; 96 Lip (10.1016/j.clinbiochem.2009.02.005_bib14) 1995; 13 Garlichs (10.1016/j.clinbiochem.2009.02.005_bib9) 2001; 104 Schwertner (10.1016/j.clinbiochem.2009.02.005_bib2) 1994; 40 Davì (10.1016/j.clinbiochem.2009.02.005_bib15) 1998; 97 Varo (10.1016/j.clinbiochem.2009.02.005_bib21) 2006; 111 Perlstein (10.1016/j.clinbiochem.2009.02.005_bib25) 2008; 28 Vachharajani (10.1016/j.clinbiochem.2009.02.005_bib42) 2000; 278 Novotny (10.1016/j.clinbiochem.2009.02.005_bib4) 2003; 228 Mylonas (10.1016/j.clinbiochem.2009.02.005_bib6) 1999; 13 Wagner (10.1016/j.clinbiochem.2009.02.005_bib13) 1993; 70 Friedewald (10.1016/j.clinbiochem.2009.02.005_bib20) 1972; 18 Phipps (10.1016/j.clinbiochem.2009.02.005_bib8) 2000; 97 Hirschfield (10.1016/j.clinbiochem.2009.02.005_bib19) 2006; 43 Mayer (10.1016/j.clinbiochem.2009.02.005_bib48) 2000; 46 Ridker (10.1016/j.clinbiochem.2009.02.005_bib45) 2007; 49 Blann (10.1016/j.clinbiochem.2009.02.005_bib16) 1995; 74 Bjelakovic (10.1016/j.clinbiochem.2009.02.005_bib29) 2007; 297 McEver (10.1016/j.clinbiochem.2009.02.005_bib36) 1990; 16 Schönbeck (10.1016/j.clinbiochem.2009.02.005_bib12) 2001; 104 Shimomura (10.1016/j.clinbiochem.2009.02.005_bib17) 1998; 81 Bulmer (10.1016/j.clinbiochem.2009.02.005_bib5) 2008; 199 Lindenblatt (10.1016/j.clinbiochem.2009.02.005_bib41) 2004; 24 Tedder (10.1016/j.clinbiochem.2009.02.005_bib37) 1995; 9 Vítek (10.1016/j.clinbiochem.2009.02.005_bib23) 2002; 160 Gokulakrishnan (10.1016/j.clinbiochem.2009.02.005_bib35) 2006; 55 Nakagami (10.1016/j.clinbiochem.2009.02.005_bib49) 1993; 1158 Blann (10.1016/j.clinbiochem.2009.02.005_bib40) 1997; 8 Yung (10.1016/j.clinbiochem.2009.02.005_bib28) 2006; 6 Schwertner (10.1016/j.clinbiochem.2009.02.005_bib7) 2008; 198 Jialal (10.1016/j.clinbiochem.2009.02.005_bib46) 2004; 44 Erdogan (10.1016/j.clinbiochem.2009.02.005_bib47) 2006; 184 Semb (10.1016/j.clinbiochem.2009.02.005_bib34) 2003; 41 Ishizaka (10.1016/j.clinbiochem.2009.02.005_bib26) 2001; 32 Breimer (10.1016/j.clinbiochem.2009.02.005_bib22) 1995; 41 Taniyama (10.1016/j.clinbiochem.2009.02.005_bib27) 2003; 42 Varo (10.1016/j.clinbiochem.2009.02.005_bib11) 2003; 107 McEver (10.1016/j.clinbiochem.2009.02.005_bib38) 1991; 45 Karmann (10.1016/j.clinbiochem.2009.02.005_bib31) 1995; 92 Ridker (10.1016/j.clinbiochem.2009.02.005_bib18) 2001; 103 Aukrust (10.1016/j.clinbiochem.2009.02.005_bib10) 1999; 100 Blann (10.1016/j.clinbiochem.2009.02.005_bib39) 1997; 128 McCarty (10.1016/j.clinbiochem.2009.02.005_bib44) 2007; 69 Schwertner (10.1016/j.clinbiochem.2009.02.005_bib24) 1998; 136 Hopkins (10.1016/j.clinbiochem.2009.02.005_bib3) 1996; 16 Hayashi (10.1016/j.clinbiochem.2009.02.005_bib43) 1999; 85 Schönbeck (10.1016/j.clinbiochem.2009.02.005_bib30) 2001; 58 Denger (10.1016/j.clinbiochem.2009.02.005_bib32) 1999; 144 |
References_xml | – volume: 104 start-page: 2395 year: 2001 end-page: 2400 ident: bib9 article-title: Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia publication-title: Circulation – volume: 1158 start-page: 189 year: 1993 end-page: 193 ident: bib49 article-title: A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin publication-title: Biochim. Biophys. Acta – volume: 32 start-page: 580 year: 2001 end-page: 583 ident: bib26 article-title: High serum bilirubin level is inversely associated with the presence of carotid plaque publication-title: Stroke – volume: 228 start-page: 568 year: 2003 end-page: 571 ident: bib4 article-title: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies publication-title: Exp. Biol. Med. – volume: 45 start-page: 156 year: 1991 end-page: 161 ident: bib38 article-title: GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium publication-title: J. Cell. Biochem. – volume: 160 start-page: 449 year: 2002 end-page: 456 ident: bib23 article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels publication-title: Atherosclerosis – volume: 100 start-page: 614 year: 1999 end-page: 620 ident: bib10 article-title: Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes publication-title: Circulation – volume: 136 start-page: 383 year: 1998 end-page: 387 ident: bib24 article-title: Association of smoking and low serum bilirubin antioxidant concentrations publication-title: Atherosclerosis – volume: 111 start-page: 341 year: 2006 end-page: 347 ident: bib21 article-title: Influence of pre-analytical and analytical factors on soluble CD40L measurements publication-title: Clin. Sci. – volume: 24 start-page: 601 year: 2004 end-page: 606 ident: bib41 article-title: Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 13 start-page: 295 year: 1999 end-page: 309 ident: bib6 article-title: Lipid peroxidation and tissue damage publication-title: In Vivo – volume: 13 start-page: 1674 year: 1995 end-page: 1678 ident: bib14 article-title: Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report publication-title: J. Hypertens. – volume: 18 start-page: 499 year: 1972 end-page: 502 ident: bib20 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin. Chem. – volume: 49 start-page: 2129 year: 2007 end-page: 2138 ident: bib45 article-title: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus publication-title: J. Am. Coll. Cardiol. – volume: 44 start-page: 6 year: 2004 end-page: 11 ident: bib46 article-title: C-reactive protein: risk marker or mediator in atherothrombosis? publication-title: Hypertension – volume: 103 start-page: 491 year: 2001 end-page: 495 ident: bib18 article-title: Soluble P-selectin and the risk of future cardiovascular events publication-title: Circulation – volume: 85 start-page: 663 year: 1999 end-page: 671 ident: bib43 article-title: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme publication-title: Circ. Res. – volume: 74 start-page: 626 year: 1995 end-page: 630 ident: bib16 article-title: von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis publication-title: Thromb. Haemost. – volume: 97 start-page: 953 year: 1998 end-page: 957 ident: bib15 article-title: Increased levels of soluble P-selectin in hypercholesterolemic patients publication-title: Circulation – volume: 63 start-page: 114 year: 1993 end-page: 116 ident: bib1 article-title: Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37 publication-title: Cytogenet. Cell Genet. – volume: 198 start-page: 1 year: 2008 end-page: 11 ident: bib7 article-title: Gilbert syndrome, UGT1A1⁎28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin publication-title: Atherosclerosis – volume: 107 start-page: 2664 year: 2003 end-page: 2669 ident: bib11 article-title: Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones publication-title: Circulation – volume: 43 start-page: 340 year: 2006 end-page: 343 ident: bib19 article-title: Gilbert's syndrome: an overview for clinical biochemists publication-title: Ann. Clin. Biochem. – volume: 28 start-page: 166 year: 2008 end-page: 172 ident: bib25 article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 144 start-page: 15 year: 1999 end-page: 23 ident: bib32 article-title: Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis publication-title: Atherosclerosis – volume: 92 start-page: 4342 year: 1995 end-page: 4346 ident: bib31 article-title: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 41 start-page: 275 year: 2003 end-page: 279 ident: bib34 article-title: Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: down regulatory effect of statin therapy publication-title: J. Am. Coll. Cardiol. – volume: 55 start-page: 237 year: 2006 end-page: 242 ident: bib35 article-title: Soluble P selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome—the Chennai Urban Rural Epidemiology Study publication-title: Metabolism – volume: 104 start-page: 2266 year: 2001 end-page: 2268 ident: bib12 article-title: Soluble CD40L and cardiovascular risk in women publication-title: Circulation – volume: 58 start-page: 4 year: 2001 end-page: 43 ident: bib30 article-title: The CD40/CD154 receptor/ligand dyad publication-title: Cell. Mol. Life Sci. – volume: 70 start-page: 105 year: 1993 end-page: 110 ident: bib13 article-title: The Weibel–Palade body: the storage granule for von Willebrand factor and P-selectin publication-title: Thromb. Haemost. – volume: 16 start-page: 250 year: 1996 end-page: 255 ident: bib3 article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 81 start-page: 397 year: 1998 end-page: 400 ident: bib17 article-title: Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction publication-title: Am. J. Cardiol. – volume: 40 start-page: 18 year: 1994 end-page: 23 ident: bib2 article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery publication-title: Clin. Chem. – volume: 97 start-page: 6930 year: 2000 end-page: 6932 ident: bib8 article-title: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 128 start-page: 135 year: 1997 end-page: 138 ident: bib39 article-title: Hypothesis: is soluble P-selectin a new marker of platelet activation? publication-title: Atherosclerosis – volume: 297 start-page: 842 year: 2007 end-page: 857 ident: bib29 article-title: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis publication-title: JAMA – volume: 96 start-page: 396 year: 1997 end-page: 399 ident: bib33 article-title: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor publication-title: Circulation – volume: 8 start-page: 383 year: 1997 end-page: 390 ident: bib40 article-title: Increased soluble P-selectin following myocardial infarction. A new marker for the progression of atherosclerosis publication-title: Blood Coagul. Fibrinolysis – volume: 278 start-page: 1613 year: 2000 end-page: 1617 ident: bib42 article-title: Heme oxygenase modulates selectin expression in different regional vascular beds publication-title: Am. J. Physiol, Heart Circ. Physiol. – volume: 6 start-page: 1 year: 2006 end-page: 19 ident: bib28 article-title: Reactive oxygen species in vascular wall publication-title: Cardiovasc. Hematol. Disord. Drug Targets – volume: 46 start-page: 1723 year: 2000 end-page: 1727 ident: bib48 article-title: Association of serum bilirubin concentration with risk of coronary artery disease publication-title: Clin. Chem. – volume: 199 start-page: 390 year: 2008 end-page: 396 ident: bib5 article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection publication-title: Atherosclerosis – volume: 184 start-page: 431 year: 2006 end-page: 437 ident: bib47 article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima–media thickness in both men and women publication-title: Atherosclerosis – volume: 42 start-page: 1075 year: 2003 end-page: 1081 ident: bib27 article-title: Reactive oxygen species in the vasculature: molecular and cellular mechanisms publication-title: Hypertension – volume: 16 start-page: 73 year: 1990 end-page: 80 ident: bib36 article-title: Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium publication-title: Blood Cells – volume: 41 start-page: 1504 year: 1995 end-page: 1508 ident: bib22 article-title: Serum bilirubin and risk of ischemic heart disease in middle-aged British men publication-title: Clin. Chem. – volume: 9 start-page: 866 year: 1995 end-page: 873 ident: bib37 article-title: The selectins: vascular adhesion molecules publication-title: FASEB J. – volume: 69 start-page: 974 year: 2007 end-page: 994 ident: bib44 article-title: “Iatrogenic Gilbert syndrome”—a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin publication-title: Med. Hypotheses – volume: 45 start-page: 156 year: 1991 ident: 10.1016/j.clinbiochem.2009.02.005_bib38 article-title: GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium publication-title: J. Cell. Biochem. doi: 10.1002/jcb.240450206 – volume: 128 start-page: 135 year: 1997 ident: 10.1016/j.clinbiochem.2009.02.005_bib39 article-title: Hypothesis: is soluble P-selectin a new marker of platelet activation? publication-title: Atherosclerosis doi: 10.1016/S0021-9150(96)05980-1 – volume: 1158 start-page: 189 year: 1993 ident: 10.1016/j.clinbiochem.2009.02.005_bib49 article-title: A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin publication-title: Biochim. Biophys. Acta doi: 10.1016/0304-4165(93)90013-X – volume: 13 start-page: 295 year: 1999 ident: 10.1016/j.clinbiochem.2009.02.005_bib6 article-title: Lipid peroxidation and tissue damage publication-title: In Vivo – volume: 32 start-page: 580 year: 2001 ident: 10.1016/j.clinbiochem.2009.02.005_bib26 article-title: High serum bilirubin level is inversely associated with the presence of carotid plaque publication-title: Stroke doi: 10.1161/01.STR.32.2.580-b – volume: 144 start-page: 15 year: 1999 ident: 10.1016/j.clinbiochem.2009.02.005_bib32 article-title: Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis publication-title: Atherosclerosis doi: 10.1016/S0021-9150(99)00033-7 – volume: 70 start-page: 105 year: 1993 ident: 10.1016/j.clinbiochem.2009.02.005_bib13 article-title: The Weibel–Palade body: the storage granule for von Willebrand factor and P-selectin publication-title: Thromb. Haemost. doi: 10.1055/s-0038-1646169 – volume: 136 start-page: 383 year: 1998 ident: 10.1016/j.clinbiochem.2009.02.005_bib24 article-title: Association of smoking and low serum bilirubin antioxidant concentrations publication-title: Atherosclerosis doi: 10.1016/S0021-9150(97)00232-3 – volume: 24 start-page: 601 year: 2004 ident: 10.1016/j.clinbiochem.2009.02.005_bib41 article-title: Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000118279.74056.8a – volume: 69 start-page: 974 year: 2007 ident: 10.1016/j.clinbiochem.2009.02.005_bib44 article-title: “Iatrogenic Gilbert syndrome”—a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin publication-title: Med. Hypotheses doi: 10.1016/j.mehy.2006.12.069 – volume: 41 start-page: 275 year: 2003 ident: 10.1016/j.clinbiochem.2009.02.005_bib34 article-title: Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: down regulatory effect of statin therapy publication-title: J. Am. Coll. Cardiol. doi: 10.1016/S0735-1097(02)02718-3 – volume: 63 start-page: 114 year: 1993 ident: 10.1016/j.clinbiochem.2009.02.005_bib1 article-title: Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37 publication-title: Cytogenet. Cell Genet. doi: 10.1159/000133513 – volume: 100 start-page: 614 year: 1999 ident: 10.1016/j.clinbiochem.2009.02.005_bib10 article-title: Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes publication-title: Circulation doi: 10.1161/01.CIR.100.6.614 – volume: 41 start-page: 1504 year: 1995 ident: 10.1016/j.clinbiochem.2009.02.005_bib22 article-title: Serum bilirubin and risk of ischemic heart disease in middle-aged British men publication-title: Clin. Chem. doi: 10.1093/clinchem/41.10.1504 – volume: 160 start-page: 449 year: 2002 ident: 10.1016/j.clinbiochem.2009.02.005_bib23 article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00601-3 – volume: 46 start-page: 1723 year: 2000 ident: 10.1016/j.clinbiochem.2009.02.005_bib48 article-title: Association of serum bilirubin concentration with risk of coronary artery disease publication-title: Clin. Chem. doi: 10.1093/clinchem/46.11.1723 – volume: 104 start-page: 2395 year: 2001 ident: 10.1016/j.clinbiochem.2009.02.005_bib9 article-title: Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia publication-title: Circulation doi: 10.1161/hc4501.099312 – volume: 199 start-page: 390 year: 2008 ident: 10.1016/j.clinbiochem.2009.02.005_bib5 article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.11.022 – volume: 43 start-page: 340 year: 2006 ident: 10.1016/j.clinbiochem.2009.02.005_bib19 article-title: Gilbert's syndrome: an overview for clinical biochemists publication-title: Ann. Clin. Biochem. doi: 10.1258/000456306778520034 – volume: 18 start-page: 499 year: 1972 ident: 10.1016/j.clinbiochem.2009.02.005_bib20 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin. Chem. doi: 10.1093/clinchem/18.6.499 – volume: 49 start-page: 2129 year: 2007 ident: 10.1016/j.clinbiochem.2009.02.005_bib45 article-title: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2007.02.052 – volume: 228 start-page: 568 year: 2003 ident: 10.1016/j.clinbiochem.2009.02.005_bib4 article-title: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies publication-title: Exp. Biol. Med. doi: 10.1177/15353702-0322805-29 – volume: 92 start-page: 4342 year: 1995 ident: 10.1016/j.clinbiochem.2009.02.005_bib31 article-title: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.92.10.4342 – volume: 104 start-page: 2266 year: 2001 ident: 10.1016/j.clinbiochem.2009.02.005_bib12 article-title: Soluble CD40L and cardiovascular risk in women publication-title: Circulation doi: 10.1161/hc4401.099447 – volume: 9 start-page: 866 year: 1995 ident: 10.1016/j.clinbiochem.2009.02.005_bib37 article-title: The selectins: vascular adhesion molecules publication-title: FASEB J. doi: 10.1096/fasebj.9.10.7542213 – volume: 13 start-page: 1674 year: 1995 ident: 10.1016/j.clinbiochem.2009.02.005_bib14 article-title: Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report publication-title: J. Hypertens. doi: 10.1097/00004872-199512010-00030 – volume: 42 start-page: 1075 year: 2003 ident: 10.1016/j.clinbiochem.2009.02.005_bib27 article-title: Reactive oxygen species in the vasculature: molecular and cellular mechanisms publication-title: Hypertension doi: 10.1161/01.HYP.0000100443.09293.4F – volume: 55 start-page: 237 year: 2006 ident: 10.1016/j.clinbiochem.2009.02.005_bib35 article-title: Soluble P selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome—the Chennai Urban Rural Epidemiology Study publication-title: Metabolism doi: 10.1016/j.metabol.2005.08.019 – volume: 278 start-page: 1613 year: 2000 ident: 10.1016/j.clinbiochem.2009.02.005_bib42 article-title: Heme oxygenase modulates selectin expression in different regional vascular beds publication-title: Am. J. Physiol, Heart Circ. Physiol. doi: 10.1152/ajpheart.2000.278.5.H1613 – volume: 107 start-page: 2664 year: 2003 ident: 10.1016/j.clinbiochem.2009.02.005_bib11 article-title: Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones publication-title: Circulation doi: 10.1161/01.CIR.0000074043.46437.44 – volume: 85 start-page: 663 year: 1999 ident: 10.1016/j.clinbiochem.2009.02.005_bib43 article-title: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme publication-title: Circ. Res. doi: 10.1161/01.RES.85.8.663 – volume: 16 start-page: 73 year: 1990 ident: 10.1016/j.clinbiochem.2009.02.005_bib36 article-title: Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium publication-title: Blood Cells – volume: 28 start-page: 166 year: 2008 ident: 10.1016/j.clinbiochem.2009.02.005_bib25 article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.107.153262 – volume: 58 start-page: 4 year: 2001 ident: 10.1016/j.clinbiochem.2009.02.005_bib30 article-title: The CD40/CD154 receptor/ligand dyad publication-title: Cell. Mol. Life Sci. doi: 10.1007/PL00000776 – volume: 97 start-page: 953 year: 1998 ident: 10.1016/j.clinbiochem.2009.02.005_bib15 article-title: Increased levels of soluble P-selectin in hypercholesterolemic patients publication-title: Circulation doi: 10.1161/01.CIR.97.10.953 – volume: 297 start-page: 842 year: 2007 ident: 10.1016/j.clinbiochem.2009.02.005_bib29 article-title: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis publication-title: JAMA doi: 10.1001/jama.297.8.842 – volume: 111 start-page: 341 year: 2006 ident: 10.1016/j.clinbiochem.2009.02.005_bib21 article-title: Influence of pre-analytical and analytical factors on soluble CD40L measurements publication-title: Clin. Sci. doi: 10.1042/CS20060047 – volume: 96 start-page: 396 year: 1997 ident: 10.1016/j.clinbiochem.2009.02.005_bib33 article-title: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor publication-title: Circulation doi: 10.1161/01.CIR.96.2.396 – volume: 184 start-page: 431 year: 2006 ident: 10.1016/j.clinbiochem.2009.02.005_bib47 article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima–media thickness in both men and women publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.05.011 – volume: 81 start-page: 397 year: 1998 ident: 10.1016/j.clinbiochem.2009.02.005_bib17 article-title: Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction publication-title: Am. J. Cardiol. doi: 10.1016/S0002-9149(97)00945-4 – volume: 40 start-page: 18 year: 1994 ident: 10.1016/j.clinbiochem.2009.02.005_bib2 article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery publication-title: Clin. Chem. doi: 10.1093/clinchem/40.1.18 – volume: 97 start-page: 6930 year: 2000 ident: 10.1016/j.clinbiochem.2009.02.005_bib8 article-title: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.97.13.6930 – volume: 103 start-page: 491 year: 2001 ident: 10.1016/j.clinbiochem.2009.02.005_bib18 article-title: Soluble P-selectin and the risk of future cardiovascular events publication-title: Circulation doi: 10.1161/01.CIR.103.4.491 – volume: 8 start-page: 383 year: 1997 ident: 10.1016/j.clinbiochem.2009.02.005_bib40 article-title: Increased soluble P-selectin following myocardial infarction. A new marker for the progression of atherosclerosis publication-title: Blood Coagul. Fibrinolysis doi: 10.1097/00001721-199710000-00002 – volume: 74 start-page: 626 year: 1995 ident: 10.1016/j.clinbiochem.2009.02.005_bib16 article-title: von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis publication-title: Thromb. Haemost. doi: 10.1055/s-0038-1649788 – volume: 16 start-page: 250 year: 1996 ident: 10.1016/j.clinbiochem.2009.02.005_bib3 article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.16.2.250 – volume: 44 start-page: 6 year: 2004 ident: 10.1016/j.clinbiochem.2009.02.005_bib46 article-title: C-reactive protein: risk marker or mediator in atherothrombosis? publication-title: Hypertension doi: 10.1161/01.HYP.0000130484.20501.df – volume: 6 start-page: 1 year: 2006 ident: 10.1016/j.clinbiochem.2009.02.005_bib28 article-title: Reactive oxygen species in vascular wall publication-title: Cardiovasc. Hematol. Disord. Drug Targets doi: 10.2174/187152906776092659 – volume: 198 start-page: 1 year: 2008 ident: 10.1016/j.clinbiochem.2009.02.005_bib7 article-title: Gilbert syndrome, UGT1A1⁎28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.01.001 |
SSID | ssj0002486 |
Score | 2.0408452 |
Snippet | To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).
The soluble... Objective - To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).... To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).OBJECTIVETo... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 791 |
SubjectTerms | Adult Atherosclerosis Atherosclerosis - blood Atherosclerosis - prevention & control Bilirubin C-Reactive Protein - metabolism CD40 Ligand - blood Enzyme-Linked Immunosorbent Assay Female Gilbert Disease - blood Gilbert's syndrome hs-CRP Humans Male P-Selectin - blood sCD40L sP-selectin Young Adult |
Title | Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis? |
URI | https://dx.doi.org/10.1016/j.clinbiochem.2009.02.005 https://www.ncbi.nlm.nih.gov/pubmed/19232335 https://www.proquest.com/docview/20084331 https://www.proquest.com/docview/67273100 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1873-2933 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002486 issn: 0009-9120 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1873-2933 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002486 issn: 0009-9120 databaseCode: ACRLP dateStart: 20080401 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Freedom Collection Journals customDbUrl: eissn: 1873-2933 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002486 issn: 0009-9120 databaseCode: AIKHN dateStart: 20080401 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-2933 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002486 issn: 0009-9120 databaseCode: AKRWK dateStart: 19670101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED9CC9leRtd9NOuXBoM9ebFly1ZKoYS0abqRsIcV-mYkSykemVNmZ4_923tny8v2EAgUbGOEBIdO0p3u43cAn4JEi9jgBhSJb70o4dpDMWI8HesY1SMjEkN2yOksntxGX-_EXQdGbS4MhVW6s7850-vT2rX03Wz2H_KccnxRuwnIuk-CTFKiOaF_4Zr-8rgO8-BRXe2ROnvUuwsf1zFelH2ocypN9ctBVxJ8p9gkozbpoLUsGu_BK6dEsmFD52vo2GIfXoza2m370J06l_kb-EOGL72wbHQZ-WyR36vCMHpL1_7dK-taOHnBFhRBVDL8u84J-6r6XLIW0uCMDRl5e1m1ZA7cAVnK1L3KUcNktSK5LJEc_OblxVu4HV_9GE08V2zBy1CmV15mJVcZ7tBYSc3nQgZBhtzFx4R-Vl-tMsMHJlIykkYaf85jk5DXEo-p2IbhO9gploU9AIY3ulAoHWR6TmhxQiUqsX5og4GWhDfWA9lOb5o5JHIqiLFI25Czn-k_nKFKmYPU5ylypgf879CHBo5jm0HnLQ_T_9ZWimJjm-GnLd9TZCM5VFRhl6uyLuFJGWebe5Cfm1woPXjfLJg11ahZ8zAUH55H3CG8bPxbZBc6gp3q98oeo5pU6ZN6H5zA7vDm22T2BEN7EuM |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1RS9xAEB7sCepLsWrrVa1bKPgUTDbZZE8K5bjWntU7fFDwbdnN7knKmRMT-_s7k2y0PhwIhSSEZQeGnd2Z2ZndbwC-RJkRqcUFKLLQBUnGTYBmxAYmNSm6R1ZkluKQk2k6vk5-3YibFRh1d2HoWKXX_a1Ob7S1bzn2o3l8XxR0xxe9m4ii-2TIpHgDq4lAndyD1eHZ-Xj6pJB50hR8pP4BEazB5-djXnQB0RRUnerOo1cSgqdYZqaWuaGNOTrdhLfej2TDltV3sOLKLVgfdeXbtmBt4rPm2_CHYl9m7tjoexKyeXGrS8vorXz7ZVA15XCKks3pEFHF8O9nQfBX9VHFOlSDEzZklPBl9YJ5fAeUKtO3ukAnkzW-5KJCdvBbVN924Pr0x9VoHPh6C0GOZr0Ocie5znGRploaPhMyinIUMD42DvNmd5VbPrCJlom00oYzntqMEpeoqVIXx--hVy5KtwsMN3Wx0CbKzYwA44TOdObC2EUDIwlyrA-yG16VezByqokxV92ps9_qH8lQscyBCrlCyfSBP5Het4gcryH62slQvZheCi3Ha8gPO7krFCPlVHTpFo9VU8WTLp0t70Gpbsqi9OFDO2GeuUbnmsex-Ph_zB3C-vhqcqEuzqbne7DRprsoTLQPvfrh0R2g11SbT35V_AWKMRWO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+CD40+ligand+and+soluble+P-selectin+levels+in+Gilbert%27s+syndrome%3A+A+link+to+protection+against+atherosclerosis%3F&rft.jtitle=Clinical+biochemistry&rft.au=Tapan%2C+Serkan&rft.au=Dogru%2C+Teoman&rft.au=Tasci%2C+Ilker&rft.au=Ercin%2C+Cemal+Nuri&rft.date=2009-06-01&rft.pub=Elsevier+Inc&rft.issn=0009-9120&rft.eissn=1873-2933&rft.volume=42&rft.issue=9&rft.spage=791&rft.epage=795&rft_id=info:doi/10.1016%2Fj.clinbiochem.2009.02.005&rft.externalDocID=S0009912009000885 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9120&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9120&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9120&client=summon |